EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacological Targeting of the NMDAR/TRPM4 Death Signaling Complex with a TwinF Interface Inhibitor Prevents Excitotoxicity-Associated Dendritic Blebbing and Organelle Damage

Omar A Ramírez iD, Andrea Hellwig, Zihong Zhang, Hilmar Bading iD

Cells · 2025

DOI: 10.3390/cells14030195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Omar A Ramírez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Interdisciplinary Center for Neurosciences (IZN), Heidelberg University, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: TRPM Cation Channels, Receptors, N-Methyl-D-Aspartate, Dendrites, Organelles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG) Forschergruppe FOR 2289, European Research Council, German Federal Ministry of Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focal swellings of dendrites (“dendritic blebbing”) together with structural damage of mitochondria and the endoplasmic reticulum (ER) are morphological hallmarks of glutamate neurotoxicity, also known as excitotoxicity. These pathological alterations are generally thought to be caused by the so-called “overactivation” of N-methyl-D-aspartate receptors (NMDARs). Here, we demonstrate that the activation of extrasynaptic NMDARs, specifically when forming a protein–protein complex with TRPM4, drives these pathological traits. In contrast, strong activation of synaptic NMDARs fails to induce cell damage despite evoking plateau-type calcium signals that are comparable to those generated by activation of the NMDAR/TRPM4 complex, indicating that high intracellular calcium levels per se are not toxic to neurons. Using confocal laser scanning microscopy and transmission electron microscopy, we show that disrupting the NMDAR/TRPM4 complex using the recently discovered small-molecule TwinF interface inhibitor FP802 inhibits the NMDA-induced neurotoxicity-associated dendritic blebbing and structural damage to mitochondria and the ER. It also prevents, at least in part, the disruption of ER–mitochondria contact sites. These findings establish the NMDAR/TRPM4 complex as the trigger for the structural damage of dendrites and intracellular organelles associated with excitotoxicity. They also suggest that activation of the NMDAR/TRPM4 complex, in addition to inducing high-amplitude, plateau-type calcium signals, generates a second signal required for glutamate neurotoxicity (“two-hit hypothesis”). As structural damage to organelles, particularly mitochondria, is a common feature of many human neurodegenerative diseases, including Alzheimer’s disease and amyotrophic lateral sclerosis (ALS), TwinF interface inhibitors have the potential to provide neuroprotection across a broad spectrum of these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPM Cation ChannelsReceptors, N-Methyl-D-AspartateDendritesOrganellesAnimalsMitochondriaEndoplasmic ReticulumHumansSignal TransductionMiceGlutamic AcidCalciumNeurons

Stichwörter der Autor:innen

ER–mitochondria contact sitesNMDAR/TRPM4 complexTwinF interface inhibitorendoplasmic reticulumglutamate neurotoxicitymitochondriaorganelle damage

Substanzen

TRPM Cation ChannelsReceptors, N-Methyl-D-AspartateGlutamic AcidCalcium

Autor:innen und Institutionen

  • Department of Neurobiology, Interdisciplinary Center for Neurosciences (IZN), Heidelberg University, 69120 Heidelberg, Germany.
  • Network Aging Research, Heidelberg University, 69115 Heidelberg, Germany.

ORCID-Profile: Omar A Ramírez, Hilmar Bading

Förderung

  • Deutsche Forschungsgemeinschaft (DFG) Forschergruppe FOR 2289
  • European Research Council
  • German Federal Ministry of Education and Research
  • Chinese Scholarship Council (CSC)

Zitieren

APA

Ramírez, O. A., Hellwig, A., Zhang, Z., & Bading, H. (2025). Pharmacological Targeting of the NMDAR/TRPM4 Death Signaling Complex with a TwinF Interface Inhibitor Prevents Excitotoxicity-Associated Dendritic Blebbing and Organelle Damage. Cells. https://doi.org/10.3390/cells14030195

Vancouver

Ramírez OA, Hellwig A, Zhang Z, Bading H. Pharmacological Targeting of the NMDAR/TRPM4 Death Signaling Complex with a TwinF Interface Inhibitor Prevents Excitotoxicity-Associated Dendritic Blebbing and Organelle Damage. Cells. 2025. doi:10.3390/cells14030195

BibTeX
@article{Ramrez2025,
  author = {Ramírez, Omar A and Hellwig, Andrea and Zhang, Zihong and Bading, Hilmar},
  title = {Pharmacological Targeting of the NMDAR/TRPM4 Death Signaling Complex with a TwinF Interface Inhibitor Prevents Excitotoxicity-Associated Dendritic Blebbing and Organelle Damage},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14030195}
}
Kostenlos starten →